ROSWELL PARK DNA REPLICATION PROG FACIL: GENET SMOKING
罗斯威尔公园 DNA 复制程序设施:基因吸烟
基本信息
- 批准号:6794339
- 负责人:
- 金额:$ 66.67万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2002
- 资助国家:美国
- 起止时间:2002-02-15 至 2003-02-14
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
DESCRIPTION (Provided by applicant): RPCI is nearing completion of a major modernization program that will replace or renovate nearly all the buildings on its 25-acre campus by the year 2002. Recent construction has made it possible to vacate a large amount of space in the Cell and Virus Building in preparation for the expansion of the Center for Cancer Genetics. Many of the investigators who remain in this building are members of the DNA Replication Program, which is an integral component of the Center for Cancer Genetics. The research focus of this highly interactive group of scientists is on aspects of DNA replication that intersect with the problem of cancer and how to effectively treat this disease. This unique program capitalizes on the unusually large amount of expertise in the field of DNA replication at RPCI and other academic institutions in the Buffalo area. The funds requested in this application will be used to renovate the second and third floors of the six-story Cell and Virus Building for occupancy by these investigators, whose programs are now housed on four different floors. With the appointment of John Cowell, Ph.D., as Chair of the Department of Cancer Genetics in 2000, an additional four recruits are anticipated into this program. Consolidation of the research activities of Program members into contiguous space will facilitate collaborations and allow for the renovation of the remaining floors of the building with other funds to eventually provide laboratory space for the expanded Center for Cancer Genetics.
描述(由申请人提供):RPCI即将完成一项重大的现代化计划,该计划将在2002年取代或翻新其25英亩校园的几乎所有建筑物。最近的建筑使得有可能在细胞和病毒建筑中腾出大量空间,以准备扩大癌症遗传学中心。留在这座建筑物中的许多研究人员都是DNA复制计划的成员,该计划是癌症遗传学中心不可或缺的组成部分。这个高度互动的科学家组的研究重点是与癌症问题以及如何有效治疗该疾病相交的DNA复制方面。这个独特的计划利用了RPCI和布法罗地区其他学术机构的DNA复制领域的异常专业知识。本申请中要求的资金将用于翻新这些调查人员的六层楼和病毒建筑的第二层和第三层,这些调查人员现在将其计划安置在四个不同的楼层上。在2000年任命约翰·科威尔(John Cowell)博士为癌症遗传学系主任的情况下,预计该计划将有四名新兵。计划成员在连续空间中的研究活动的整合将有助于合作,并允许建筑物的其余楼层与其他资金进行翻新,以最终为扩大的癌症遗传学中心提供实验室空间。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
YOUCEF M RUSTUM其他文献
YOUCEF M RUSTUM的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('YOUCEF M RUSTUM', 18)}}的其他基金
IMPROVING ANIMAL RESOURCES FOR CANCER RESEARCH AT RPCI
改善 RPCI 癌症研究的动物资源
- 批准号:
6769193 - 财政年份:2004
- 资助金额:
$ 66.67万 - 项目类别:
Irinotecan in Combination with Celecoxib: A phase I Stu*
伊立替康联合塞来昔布:I 期研究*
- 批准号:
6801508 - 财政年份:2003
- 资助金额:
$ 66.67万 - 项目类别:
ROSWELL PARK DNA REPLICATION PROG FACIL: ANTITUMOR DRUG
罗斯威尔公园 DNA 复制程序设施:抗肿瘤药物
- 批准号:
6794340 - 财政年份:2002
- 资助金额:
$ 66.67万 - 项目类别:
ROSWELL PARK DNA REPLICATION PROG FACIL: STEM CELL
罗斯威尔公园 DNA 复制程序设施:干细胞
- 批准号:
6794341 - 财政年份:2002
- 资助金额:
$ 66.67万 - 项目类别:
THYMIDYLATE SYNTHASE INHIBITORS IN HEAD AND NECK CANCER
胸苷酸合酶抑制剂治疗头颈癌
- 批准号:
2443123 - 财政年份:1995
- 资助金额:
$ 66.67万 - 项目类别:
THYMIDYLATE SYNTHASE INHIBITORS IN HEAD AND NECK CANCER
胸苷酸合酶抑制剂治疗头颈癌
- 批准号:
2696929 - 财政年份:1995
- 资助金额:
$ 66.67万 - 项目类别:
THYMIDYLATE SYNTHASE INHIBITORS IN HEAD AND NECK CANCER
胸苷酸合酶抑制剂治疗头颈癌
- 批准号:
2895208 - 财政年份:1995
- 资助金额:
$ 66.67万 - 项目类别:
THYMIDYLATE SYNTHASE INHIBITORS IN HEAD AND NECK CANCER
胸苷酸合酶抑制剂治疗头颈癌
- 批准号:
2108882 - 财政年份:1995
- 资助金额:
$ 66.67万 - 项目类别:
THYMIDYLATE SYNTHASE INHIBITORS IN HEAD AND NECK CANCER
胸苷酸合酶抑制剂治疗头颈癌
- 批准号:
2108881 - 财政年份:1995
- 资助金额:
$ 66.67万 - 项目类别:
相似海外基金
Communicore Animal Facility (CAF) Renovation Phase III Part II
Communicore 动物设施 (CAF) 改造第三期第二部分
- 批准号:
7248297 - 财政年份:2007
- 资助金额:
$ 66.67万 - 项目类别:
Planning the Stanford Center for Translational Medicine
规划斯坦福转化医学中心
- 批准号:
7215020 - 财政年份:2006
- 资助金额:
$ 66.67万 - 项目类别:
Center for Research in Emerging Infections and Vaccines
新发感染和疫苗研究中心
- 批准号:
6950152 - 财政年份:2005
- 资助金额:
$ 66.67万 - 项目类别:
BSL3 AND ABSL3 FACIL: WEST NILE, DENGUE, BUNYAVIRUSES
BSL3 和 ABSL3 FACIL:西尼罗河病毒、登革热病毒、布尼亚病毒
- 批准号:
7153748 - 财政年份:2005
- 资助金额:
$ 66.67万 - 项目类别:
EXTRAMURAL RESEARCH FACILITIES CONSTRUCTION: CANCER
校外研究设施建设:癌症
- 批准号:
7153797 - 财政年份:2005
- 资助金额:
$ 66.67万 - 项目类别: